363 related articles for article (PubMed ID: 18639341)
1. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity.
Hoshi M; Ito H; Fujigaki H; Takemura M; Takahashi T; Tomita E; Ohyama M; Tanaka R; Saito K; Seishima M
Leuk Res; 2009 Jan; 33(1):39-45. PubMed ID: 18639341
[TBL] [Abstract][Full Text] [Related]
2. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
3. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
4. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
Pertovaara M; Raitala A; Lehtimäki T; Karhunen PJ; Oja SS; Jylhä M; Hervonen A; Hurme M
Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Masaki A; Ishida T; Maeda Y; Suzuki S; Ito A; Takino H; Ogura H; Totani H; Yoshida T; Kinoshita S; Narita T; Ri M; Kusumoto S; Inagaki A; Komatsu H; Niimi A; Ueda R; Utsunomiya A; Inagaki H; Iida S
Clin Cancer Res; 2015 Jun; 21(12):2830-9. PubMed ID: 25788494
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
Sperner-Unterweger B; Neurauter G; Klieber M; Kurz K; Meraner V; Zeimet A; Fuchs D
Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828
[TBL] [Abstract][Full Text] [Related]
11. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
Cozzi A; Zignego AL; Carpendo R; Biagiotti T; Aldinucci A; Monti M; Giannini C; Rosselli M; Laffi G; Moroni F
J Viral Hepat; 2006 Jun; 13(6):402-8. PubMed ID: 16842443
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
Pertovaara M; Raitala A; Uusitalo H; Pukander J; Helin H; Oja SS; Hurme M
Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
[TBL] [Abstract][Full Text] [Related]
13. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
Sakurai K; Matsuo S; Enomoto K; Tani M; Kitajima A; Amano S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2007 Feb; 44(5):1011-4. PubMed ID: 16620985
[TBL] [Abstract][Full Text] [Related]
15. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
[TBL] [Abstract][Full Text] [Related]
18. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy].
Sakurai K; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2265-7. PubMed ID: 19106591
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
Weinlich G; Murr C; Richardsen L; Winkler C; Fuchs D
Dermatology; 2007; 214(1):8-14. PubMed ID: 17191041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
